Home/AltrixBio/David Pass
DP

David Pass

CEO and President

AltrixBio

AltrixBio Pipeline

DrugIndicationPhase
AJN003 (LuCI™)Type 2 DiabetesPre-clinical
AJN003 PlatformObesity / Weight ManagementPre-clinical